2,3-Difluorobenzaldehyde

We are 2,3-Difluorobenzaldehyde CAS:2646-91-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,3-Difluorobenzaldehyde
CAS.NO:2646-91-5
Synonyms:BENZALDEHYDE,2,3-DIFLUORO;
2,3-difluoro-benzaldehyde;
Molecular Formula:C7H4F2O
Molecular Weight:142.10300
 
Physical and Chemical Properties:
Density:1.301;
Boiling point:69-70oC;
Flash point:58oC;
Index of Refraction:1.499;
 
Specification:
Appearance:Colorless to yellow transparent liquid
Purity(GC):≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:2,3-Difluorobenzaldehyde, is the fluorinated building block used for the synthesis of more complex pharmaceutical and biologically active compounds, such as Cyclopentapyridine and Thienopyridine derivatives as potential calcium channel Modulators.
 

2,3-Difluorobenzaldehyde


Related News: Steven M. Fruchtman, M.D., President and Chief Executive Officer of Onconova, added “The rigosertib Pre-approval Access Program is a key strategic initiative for Onconova.2-mercaptobencimidazol CAS:583-39-1 Retrogenix holds two Queen’s Awards for Enterprise, the UK’s most prestigious acknowledgement of business performance. The company is headquartered near Manchester, UK, and has an office in Cambridge, MA.methyl (E)-3-(methoxy(phenyl)methylene)-2-oxoindoline-6-carboxylate CAS:1168150-46-6 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.(2-bromo-4-fluorophenyl)methanol CAS:229027-89-8 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.The increase in environmental protection pressure has also increased the environmental protection expenditure of pharmaceutical manufacturing companies, which forced some small production capacity to withdraw from the market, increased industry concentration, and brought certain opportunities for API manufacturers.

Related Products
Product Name
(1-ethylpyrrolidin-2-yl)methanamine View Details
1-Methylindole View Details
3,3-Difluorocyclobutanecarboxylic acid Cas:107496-54-8 View Details
2,6-Dimethyl-3-nitropyridine manufacturer axitinib Cas:319460-85-0 manufacturer N-(hydroxymethyl)phthalimide manufacturer (2R,3R)-Diisopropyl 2,3-dihydroxysuccinate manufacturer N,O-dimethyl-N’-nitroisourea manufacturer